Literature DB >> 20093746

Expression of HSP27, HSP72 and MRP proteins in in vitro co-culture of colon tumour cell spheroids with normal cells after incubation with rhTGF- beta1 and/or CPT-11.

Roman Paduch1, Joanna Jakubowicz-Gil, Martyna Kandefer-Szerszen.   

Abstract

We studied the expression of inducible heat shock protein (HSP27, HSP72) and multidrug-resistance protein (MRP) in co-cultures of human colon carcinoma cell spheroids obtained from different grades of tumour with normal human colon epithelium, myofibroblast and endothelial cell monolayers. We also measured the influence of recombinant human transforming growth factor beta1 (rhTGF-beta1) and camptothecin (CPT-11), added as single agents or in combination, on the levels of the HSPs, MRP, interleukin (IL)-6 and nitric oxide (NO). An immunoblotting analysis with densitometry showed that rhTGF-beta1 and/or CPT-11 increased HSP27, HSP72 and MRP expression in tumour cells and myofibroblasts, as well as in co-cultures compared with appropriate controls. By contrast, in colonic epithelium, inhibition of HSPs and MRP was comparable with that of the control. In endothelial cells, HSP72 was undetectable. Direct interaction of colon tumour spheroids with normal myofibroblasts caused a significant, tumour-grade dependent increase in IL-6 production. Production of IL-6 was significantly lowered by rhTGF-beta1 and/or CPT-11. Tumour cell spheroids cultivated alone produced larger amounts of NO than normal cells. In co-culture, the level of the radical decreased compared with the sum of NO produced by the monocultures of the two types of cells. rhTGF-beta1 and/or CPT-11 decreased NO production both in tumour and normal cell monocultures and their co-cultures. In conclusion, direct interactions between tumour and normal cells influence the expression of HSP27, HSP72 and MRP, and alter IL-6 and NO production. rhTGF-beta1 and/or CPT-11 may potentate resistance to chemotherapy by increasing HSP and MRP expression but, on the other hand, they may limit tumour cell spread by decreasing the level of some soluble mediators of inflammation (IL-6 and NO).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20093746     DOI: 10.1007/s12038-009-0107-2

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  28 in total

Review 1.  Multidrug resistance: molecular mechanisms and clinical relevance.

Authors:  V Ling
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

2.  Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.

Authors:  R Paduch; M Kandefer-Szerszeń
Journal:  Cell Biol Toxicol       Date:  2005 Sep-Nov       Impact factor: 6.691

3.  Induction of heat shock protein 72 by a nitric oxide donor in guinea-pig gastric mucosal cells.

Authors:  C R Byrne; P J Hanson
Journal:  Eur J Pharmacol       Date:  1998-07-17       Impact factor: 4.432

4.  Upregulation by retinoic acid of transforming growth factor-beta-stimulated heat shock protein 27 induction in osteoblasts: involvement of mitogen-activated protein kinases.

Authors:  Daijiro Hatakeyama; Osamu Kozawa; Masayuki Niwa; Hiroyuki Matsuno; Hidenori Ito; Kanefusa Kato; Norichika Tatematsu; Toshiyuki Shibata; Toshihiko Uematsu
Journal:  Biochim Biophys Acta       Date:  2002-02-13

5.  Expression of multidrug resistance protein in metastatic colorectal carcinomas.

Authors:  A Nanashima; H Yamaguchi; S Matsuo; Y Sumida; T Tsuji; T Sawai; T Yasutake; T Nakagoe; H Ayabe
Journal:  J Gastroenterol       Date:  1999-10       Impact factor: 7.527

6.  Study of interleukin-6 in the spread of colorectal cancer: the diagnostic significance of IL-6.

Authors:  Tatsuto Ashizawa; Ryosuke Okada; Yoshiaki Suzuki; Makoto Takagi; Tatsuyuki Yamazaki; Tetsuo Sumi; Toshiaki Aoki; Tatsuya Aoki
Journal:  Acta Med Okayama       Date:  2006-12       Impact factor: 0.892

7.  Markers of drug resistance in relapsing colon cancer.

Authors:  A C Lazaris; N G Kavantzas; H S Zorzos; N V Tsavaris; P S Davaris
Journal:  J Cancer Res Clin Oncol       Date:  2001-11-30       Impact factor: 4.553

8.  Heat shock provides delayed protection against oxidative injury in cultured human umbilical vein endothelial cells.

Authors:  R R Gill; C J Gbur; B J Fisher; M L Hess; A A Fowler; R C Kukreja; M M Sholley
Journal:  J Mol Cell Cardiol       Date:  1998-12       Impact factor: 5.000

9.  IL-6 activates HSP72 gene expression in human skeletal muscle.

Authors:  Mark A Febbraio; Adam Steensberg; Christian P Fischer; Charlotte Keller; Natalie Hiscock; Bente Klarlund Pedersen
Journal:  Biochem Biophys Res Commun       Date:  2002-09-06       Impact factor: 3.575

Review 10.  CPT-11 (irinotecan) in the treatment of colorectal cancer.

Authors:  J P Armand; M Ducreux; M Mahjoubi; D Abigerges; R Bugat; G Chabot; P Herait; M de Forni; P Rougier
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

View more
  3 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

2.  Protective effects of transforming growth factor β2 in intestinal epithelial cells by regulation of proteins associated with stress and endotoxin responses.

Authors:  Duc Ninh Nguyen; Pingping Jiang; Susanne Jacobsen; Per T Sangild; Emøke Bendixen; Dereck E W Chatterton
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

3.  Chronic inflammation in cancer development.

Authors:  Gabriele Multhoff; Michael Molls; Jürgen Radons
Journal:  Front Immunol       Date:  2012-01-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.